تاریخچه درآمد، سود و جریان نقد از صورتهای مالی رسمی.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
نمودارهای تعاملی و صورتهای مالی کامل ← مدل ارزشگذاری (DCF) ←
| صورت سود و زیان | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| مجموع درآمد | $21.0B | $20.1B | $16.7B | $14.2B | $12.7B | $11.9B | $9.9B | $10.7B | $9.8B | $9.0B | $8.4B | $7.5B | $7.4B | $7.1B | $7.2B | $7.6B | $7.8B | $8.2B | $8.1B | $8.4B | $7.8B |
| سود ناخالص | $14.9B | $13.9B | $10.3B | $8.8B | $7.7B | $7.5B | $5.6B | $6.9B | $6.5B | $5.9B | $5.3B | $4.6B | $4.6B | $4.5B | $4.6B | $4.7B | $4.8B | $5.2B | $5.1B | $5.4B | $5.1B |
| حاشیه سود ناخالص % | 71.2% | 69.0% | 61.3% | 62.0% | 60.8% | 62.8% | 56.2% | 64.1% | 65.9% | 64.9% | 63.7% | 61.0% | 62.2% | 63.5% | 62.9% | 61.4% | 61.3% | 63.2% | 63.2% | 64.6% | 65.0% |
| سود عملیاتی (EBIT) | $4.6B | $4.0B | $2.6B | $2.2B | $1.8B | $1.9B | $601M | $1.7B | $1.7B | $1.5B | $1.2B | $790M | $845M | $871M | $994M | $1.1B | $1.1B | $1.3B | $1.3B | $1.2B | $1.2B |
| حاشیه سود عملیاتی % | 21.8% | 19.8% | 15.7% | 15.3% | 14.4% | 16.2% | 6.1% | 16.0% | 17.7% | 16.9% | 14.7% | 10.6% | 11.5% | 12.2% | 13.7% | 14.7% | 13.8% | 15.9% | 16.1% | 14.1% | 15.8% |
| سود خالص | $3.7B | $2.9B | $1.9B | $1.6B | $698M | $1.0B | ($82M) | $4.7B | $1.7B | $104M | $347M | ($239M) | ($119M) | ($121M) | ($4.1B) | $441M | ($1.1B) | ($1.0B) | ($2.0B) | ($495M) | ($3.6B) |
| حاشیه سود خالص % | 17.5% | 14.4% | 11.1% | 11.2% | 5.5% | 8.8% | -0.8% | 43.8% | 17.0% | 1.1% | 4.1% | -3.2% | -1.6% | -1.7% | -56.1% | 5.8% | -13.6% | -12.5% | -25.3% | -5.9% | -45.7% |
| EBITDA | — | $5.1B | $3.9B | $3.5B | $2.7B | $2.5B | $1.5B | $2.2B | $2.6B | $2.0B | $1.2B | $360M | $433M | $721M | ($3.2B) | $1.6B | $149M | ($108M) | ($699M) | $940M | ($2.3B) |
| سود هر سهم (EPS) | $2.45 | $1.93 | $1.25 | $1.09 | $0.48 | $0.73 | $-0.06 | $3.33 | $1.19 | $0.07 | $0.25 | $-0.18 | $-0.09 | $-0.09 | $-2.89 | $0.29 | $-0.70 | $-0.68 | $-1.36 | $-0.33 | $-2.81 |
| سهام منتشرشده (میلیون) | — | 1,494M | 1,486M | 1,464M | 1,440M | 1,434M | 1,417M | 1,411M | 1,401M | 1,393M | 1,377M | 1,341M | 1,348M | 1,341M | 1,407M | 1,519M | 1,518M | 1,508M | 1,498M | 1,487M | 1,274M |
منبع: گزارشهای عمومی شرکت (SEC). پیش از اتکا به هر رقم، آن را در SEC EDGAR بررسی کنید.
ترازنامهها، جریانهای نقدی، دادههای فصلی و نسبتهای مالی کامل در نمایشگر تعاملی BSX در دسترس است. /companies/us/BSX
اطلاعات این وبسایت صرفاً برای اهداف آموزشی و اطلاعرسانی است و توصیه سرمایهگذاری نیست. هیچ هدف قیمتی یا توصیهای منتشر نمیشود.
About TickerBase · Data methodology & sources · Privacy · Terms